Adjuvant treatment for gastric cancer: chemotherapy versus radiation
N Ashraf, S Hoffe, R Kim - The Oncologist, 2013 - academic.oup.com
Adjuvant Treatment for Gastric Cancer: Chemotherapy Versus Radiation | The Oncologist | Oxford
Academic Skip to Main Content Advertisement Oxford Academic Journals Books Search Menu …
Academic Skip to Main Content Advertisement Oxford Academic Journals Books Search Menu …
Postoperative chemoradiotherapy versus chemotherapy for R0 resected gastric cancer with D2 lymph node dissection: an up-to-date meta-analysis
M Zhou, M Kang, G Li, X Guo, Z Zhang - World journal of surgical oncology, 2016 - Springer
Background This meta-analysis aims to provide more evidence on the role of postoperative
chemoradiotherapy (CRT) for gastric cancer (GC) patients in Asian countries where D2 …
chemoradiotherapy (CRT) for gastric cancer (GC) patients in Asian countries where D2 …
Adjuvant chemoradiation versus chemotherapy in completely resected advanced gastric cancer with D2 nodal dissection
HC KWON, MC Kim, KH Kim, JS Jang… - Asia‐Pacific Journal …, 2010 - Wiley Online Library
Aim: Adjuvant chemoradiation has become a standard of care in the USA. We evaluated the
efficacy and toxicity of adjuvant chemoradiation versus chemotherapy in completely …
efficacy and toxicity of adjuvant chemoradiation versus chemotherapy in completely …
[HTML][HTML] Overexpressed circ-RPL15 predicts poor survival and promotes the progression of gastric cancer via regulating miR-502-3p/OLFM4/STAT3 pathway
Y Li, Y Gong, J Ma, X Gong - Biomedicine & Pharmacotherapy, 2020 - Elsevier
Background Increasing studies have revealed that circular RNAs (circRNAs) contribute to
gastric cancer (GC) progression. The circular RNA ribosomal protein L15 (circ-RPL15) is …
gastric cancer (GC) progression. The circular RNA ribosomal protein L15 (circ-RPL15) is …
Demographic disparities in patterns of care and survival outcomes for patients with resected gastric adenocarcinoma
AM Stessin, DL Sherr - Cancer Epidemiology, Biomarkers & Prevention, 2011 - AACR
Background: Several reports showed incomplete adoption of adjuvant radiotherapy (RT) for
resectable gastric cancer since the publication of Intergroup 0116 trial results. The aims of …
resectable gastric cancer since the publication of Intergroup 0116 trial results. The aims of …
Adjuvant chemoradiation for resected gastric cancer: a 10-year experience
ATY Chang, WT Ng, ALY Law, KM Ku, MCH Lee… - Gastric Cancer, 2011 - Springer
Abstract Background The Intergroup 0116 study demonstrated that concurrent
chemoradiation improved overall survival (OS) in resected gastric cancer. However, there …
chemoradiation improved overall survival (OS) in resected gastric cancer. However, there …
Is postoperative adjuvant chemoradiotherapy efficacious and safe for gastric cancer patients with D2 lymphadenectomy? A meta-analysis of the literature
JW Liang, ZC Zheng, T Yu, X Wang, JJ Zhang - European Journal of …, 2014 - Elsevier
Backgroud Adjuvant chemoradiotherapy (CRT) for patients with gastric cancer after D2
lymphadenectomy remains controversial. The objective of the present meta-analysis was to …
lymphadenectomy remains controversial. The objective of the present meta-analysis was to …
Adjuvant therapy for elderly patients with resected gastric adenocarcinoma: Population‐based practices and treatment effectiveness
KE Hoffman, BA Neville, HJ Mamon, LA Kachnic… - Cancer, 2012 - Wiley Online Library
BACKGROUND: A study was undertaken to determine the survival benefit of postoperative
chemoradiation therapy for elderly patients with resected gastric adenocarcinoma …
chemoradiation therapy for elderly patients with resected gastric adenocarcinoma …
Can the addition of radiotherapy postoperatively increase clinical outcome of patients with gastric cancer? A systematic review of the literature and meta-analysis
F Fiorica, M Trovò, A Ottaiano, G Nasti… - …, 2017 - pmc.ncbi.nlm.nih.gov
Background Although several studies have been carried out to determine the best treatment
for gastric carcinoma, the data on survival rate still remain inconclusive. Objective To …
for gastric carcinoma, the data on survival rate still remain inconclusive. Objective To …
The extent of lymph node dissection for gastric cancer: a critical appraisal
E De Bree, V Charalampakis… - Journal of Surgical …, 2010 - Wiley Online Library
The extent of lymphadenectomy during therapeutic gastrectomy for gastric cancer remains a
protracted and controversial issue. While traditionally extended lymphadenectomy is …
protracted and controversial issue. While traditionally extended lymphadenectomy is …